Despite what the name suggests, Polycystic Ovary Syndrome isn’t just about ovaries—or cysts, for that matter. In fact, many people diagnosed with PCOS don’t have any ovarian cysts at all. Confusing? You’re not alone. The name dates back to how the condition was first described, but science has come a long way since then. Today, we understand that PCOS is really a complex hormonal and metabolic condition that affects far more than reproductive health.
At its core, PCOS is about hormonal imbalance. When key hormones like insulin, androgens (like testosterone), and others are out of sync, they can create a domino effect throughout the body. This hormonal miscommunication can lead to irregular periods, acne, weight changes, hair loss or excess hair growth, difficulty with ovulation or fertility—and that’s just the shortlist. But here’s the thing: PCOS doesn’t follow a single pattern. Some women experience textbook symptoms. Others don’t fit the mold at all. That’s part of what makes PCOS so challenging—and why understanding your unique experience matters.
So, how can the PCOS Association help?
We’re here to offer more than definitions. We’re here to offer direction. Whether you’re newly diagnosed, still searching for answers, or years into your journey and feeling stuck, we’re committed to helping you make sense of PCOS—and make progress.
Here’s what you’ll find at PCOSA:
✅ Reliable, science-backed information about what PCOS is (and isn’t)
💬 Supportive communities of people who understand exactly what you’re going through
🧬 Resources for navigating fertility, metabolic health, nutrition, and more
🧠 Education for providers who want to better support their PCOS patients
🙋♀️ Advocacy to make sure PCOS is recognized, researched, and respected
No fluff. No fad cures. Just real support, grounded in evidence and compassion.
At PCOSA, we believe every person with PCOS deserves to be informed, empowered, and heard. Wherever you are in your journey, we’re honored to walk with you.
pcos: Latest results from PubMed
CONCLUSION: High androgen induced pyroptosis of ovarian granulosa cells in a mouse model of PCOS, leading to ER stress in oocytes and a decrease of the oocyte maturation rate. Effective alleviation of granulosa cell pyroptosis can inhibit ER stress in oocytes and improve their maturation rate. This study provides new therapeutic targets for improving oocyte maturation in PCOS.
Published on: Sat, 29 Nov 2025 06:00:00 -0500
Authors: Yan Zhang, Xianguo Xie, Lei Han,
Polycystic ovary syndrome (PCOS) is a multifactorial disorder driven by at least three pathophysiological components: hypothalamic, ovarian, and obesity-related mechanisms. Insulin resistance (IR) is a unifying feature. Reciprocal interactions among androgen excess, hyperinsulinemia, and reduced hepatic sex hormone-binding globulin production create a self‑sustaining "vicious cycle" that exacerbates PCOS manifestations, which vary in severity and define four clinical phenotypes. To evaluate...
Published on: Fri, 28 Nov 2025 06:00:00 -0500
Authors: Piotr Szkodziak, Filip Szkodziak, Kamila Trzeciak, Sławomir Woźniak, Margaret Mlynarczyk, Tomasz Paszkowski,
CONCLUSIONS: In our cohort, curves treated using a novel rod with increased rigidity, comparable corrections were achieved regardless of whether PCO was performed. We noted a higher intraoperative EBL and longer operative times when PCOs were utilized.
Published on: Fri, 28 Nov 2025 06:00:00 -0500
Authors: Luke Mugge, William F Lavelle, Mark Rahm, Matthew E Cunningham, Shyam Kishan, Dennis R Knapp, Randolph Gray, Laurel C Blakemore,
PURPOSE OF REVIEW: Sex steroid hormones and the gut microbiome are increasingly recognized as bidirectionally interacting regulators of growth, metabolism, and endocrine maturation. While most research has focused on adults, accumulating evidence indicates that these interactions are established early in life and influence pubertal timing, metabolic homeostasis, and neuroendocrine development. This review synthesizes current human evidence on microbiome-sex steroid relationships across childhood...
Published on: Fri, 28 Nov 2025 06:00:00 -0500
Authors: Gianvincenzo Zuccotti, Valeria Calcaterra,
CONCLUSIONS: The 5A's model and educational booklets to improve self-management increased quality of life and self-efficacy of women with PCOS, which can be used in clinical settings for healthcare providers.
Published on: Fri, 28 Nov 2025 06:00:00 -0500
Authors: Fatemeh Goodarzi, Shahnaz Mojahed, Fatemeh ZareMobini, Mohammadtaghi Sarebanhassanabadi,
PURPOSE OF REVIEW: Alongside its impact on cardio-metabolic parameters, obesity has been linked to infertility. This article aimed to provide a comprehensive review of the most current evidence linking male and female obesity and infertility.
Published on: Fri, 28 Nov 2025 06:00:00 -0500
Authors: Sairabanu Mohamed Rashid Sokwalla, Swafiya Busaidy, Gautam Das,
CONCLUSION: Digital health interventions represent a valuable adjunct in the long-term management of PCOS, demonstrating efficacy across clinical, behavioral, and psychological domains.
Published on: Fri, 28 Nov 2025 06:00:00 -0500
Authors: Min Xie, Xuemei Qing, Hailong Huang, Bangfang Xie, Jing Zhang,
Polycystic Ovary Syndrome (PCOS) is a prevalent endocrine disorder affecting women of reproductive age, characterized by hormonal imbalance, irregular menstrual cycles, and ovarian cysts. Traditional diagnostic approaches, which include clinical evaluations, radiological studies, and surgical interventions, are often time-consuming, costly, and not always reliable. To improve the accuracy and efficiency of PCOS diagnosis, this research introduces the Feature Fusion Context Attention U-Net...
Published on: Thu, 27 Nov 2025 06:00:00 -0500
Authors: Yuvaraj Natarajan, Sri Preethaa K R, Shyamala Devi M,
CONCLUSION: Our data indicates inherent defects in metabolism in follicular compartment in women with PCOS which may affect oocyte quality. Understanding energy dynamics in the follicle can offer valuable insights about key metabolites to be added to oocyte/embryo culture media in IVF settings and may highlight plausible markers for oocyte/embryo quality.
Published on: Thu, 27 Nov 2025 06:00:00 -0500
Authors: Aalaap Naigaonkar, Gayatri Shinde, Sushma Khavlae, Indira Hinduja, Srabani Mukherjee,
This study aimed to investigate the association between the SOD1 gene I>D polymorphism, a key component of the antioxidant defense system, and polycystic ovary syndrome (PCOS), as well as to evaluate the potential effects of this genetic variation on genotypic distribution and metabolic parameters. A total of 100 PCOS patients and 135 healthy controls were included, and genomic DNA extracted from peripheral blood was analyzed for the SOD1 I>D polymorphism using conventional PCR, while clinical...
Published on: Thu, 27 Nov 2025 06:00:00 -0500
Authors: Mehmet Can Nacar, Recai Aci̇, Şengül Tural, Serbülent Yi̇ği̇t,
CONCLUSION: Women with PCOS show significantly higher VAI and LAP values than those without this syndrome.
Published on: Thu, 27 Nov 2025 06:00:00 -0500
Authors: Juan R Ulloque-Badaracco, Enrique A Hernandez-Bustamante, Juan C Cabrera-Guzmán, Jose E Delgado-Raygada, Giuseppe Dotto-Vasquez, Gian F Maldonado-Basurto, Alberto A Figueroa-Larragán, Katherin Z Trujillo-Jurado, Gustavo Evaristo-Ballmann, Aldo Flores-Gavino, Percy Herrera-Añazco, Vicente A Benites-Zapata,
CONCLUSION: Impaired sexual function in infertile women diagnosed with PCOS can be more associated with PCOS-related complications and other concurrent factors that affect sexual function rather than infertility. It seems that the effects of infertility on sexual function can be different in infertile women according to each person's condition. Hence, screening for sexual dysfunction in women with PCOS and infertility should be deemed as a part of clinical assessment, leading to early diagnosis...
Published on: Thu, 27 Nov 2025 06:00:00 -0500
Authors: Khadijeh Azarbayjani, Shahideh Jahanian Sadatmahalleh, Negin Mirzaei, Mahsa Yarjanly, Nadia Jahangiri, Malihe Nasiri, Mona Zeinaloo,
Etomidate (ETO), a benzodiazepine commonly used by pregnant women with anxiety disorders, has been increasingly detected in aquatic environments. However, its reproductive toxicity and intergenerational effects have not been adequately assessed. In this study, adult female fish were employed to investigate the reproductive toxicity after ETO exposure. After 4 weeks of exposure, zebrafish ovaries exhibited polycystic ovary syndrome (PCOS)-like changes, including polycystic ovaries, reduced...
Published on: Thu, 27 Nov 2025 06:00:00 -0500
Authors: Xuewei Li, Xuhui Lin, Zile Zhuang, Yuxuan Luo, Yihan Li, Said Ahmed Isse, Zhenzhong Chen, Fanliang Meng, Qizhi Luo, Bofeng Zhu, Xuncai Chen,
CONCLUSION: MT may serve as a promising therapeutic candidate for PCOS, as verified by the network pharmacology approach based on data mining and molecular docking methods. However, further in vivo and in vitro experiments are needed.
Published on: Thu, 27 Nov 2025 06:00:00 -0500
Authors: Qing Jiang, Danfeng Pu, Yun Hu, Ruoyan Wu, Chenjie Jiang, Shiqin Yuan, Xiaowei Zhu, Lan Xu,
Polycystic ovary syndrome (PCOS) is a complex endocrine-metabolic disorder affecting 6-20% of women of reproductive age, manifesting through hyperandrogenism, ovulatory dysfunction, insulin resistance, and diverse metabolic derangements. Increasing evidence highlights the contribution of environmental factors, particularly endocrine-disrupting chemicals (EDCs), to PCOS susceptibility and severity. Sunscreen ultraviolet (UV) filters such as oxybenzone (benzophenone-3) and octinoxate (ethylhexyl...
Published on: Thu, 27 Nov 2025 06:00:00 -0500
Authors: Sulagna Dutta, Pallav Sengupta, Bhupender S Chhikara, Grzegorz Formicki, Israel Maldonado Rosas, Shubhadeep Roychoudhury,